Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Oct 31, 2025 | (Q2)Jul 31, 2025 | (Q1)Apr 30, 2025 | (FY)Jan 31, 2025 | (Q4)Jan 31, 2025 | (Q3)Oct 31, 2024 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -8.68%2.95K | 486.11%9.24K | 77.13%6.18K | 27.57%29.61K | 216.28%21.31K | -13.95%3.23K | -81.09%1.58K | -20.36%3.49K | -8.75%23.21K | -30.14%6.74K |
| Selling and administrative expenses | 32.93%1.42K | 300.66%1.52K | 54.59%1.65K | 116.59%20.54K | 722.90%19.16K | 0.00%1.07K | -119.03%-755 | -49.58%1.07K | -22.14%9.48K | -57.81%2.33K |
| -General and administrative expense | 32.93%1.42K | 300.66%1.52K | 54.59%1.65K | 116.59%20.54K | 722.90%19.16K | 0.00%1.07K | -119.03%-755 | -49.58%1.07K | -22.14%9.48K | -57.81%2.33K |
| Other operating expenses | -29.31%1.52K | 231.39%7.73K | 87.08%4.53K | -33.94%9.07K | -51.10%2.16K | -19.52%2.16K | -46.65%2.33K | 6.98%2.42K | 3.55%13.73K | 6.86%4.41K |
| Operating profit | 8.68%-2.95K | -486.11%-9.24K | -77.13%-6.18K | -27.57%-29.61K | -216.28%-21.31K | 13.95%-3.23K | 81.09%-1.58K | 20.36%-3.49K | 8.75%-23.21K | 30.14%-6.74K |
| Net non-operating interest income (expenses) | ||||||||||
| Other net income (expenses) | ||||||||||
| Income before tax | 8.68%-2.95K | -486.11%-9.24K | -77.13%-6.18K | -27.57%-29.61K | -216.28%-21.31K | 13.95%-3.23K | 81.09%-1.58K | 20.36%-3.49K | 8.75%-23.21K | 30.14%-6.74K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 8.68%-2.95K | -486.11%-9.24K | -77.13%-6.18K | -27.57%-29.61K | -216.28%-21.31K | 13.95%-3.23K | 81.09%-1.58K | 20.36%-3.49K | 8.75%-23.21K | 30.14%-6.74K |
| Net income continuous operations | 8.68%-2.95K | -486.11%-9.24K | -77.13%-6.18K | -27.57%-29.61K | -216.28%-21.31K | 13.95%-3.23K | 81.09%-1.58K | 20.36%-3.49K | 8.75%-23.21K | 30.14%-6.74K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 8.68%-2.95K | -486.11%-9.24K | -77.13%-6.18K | -27.57%-29.61K | -216.28%-21.31K | 13.95%-3.23K | 81.09%-1.58K | 20.36%-3.49K | 8.75%-23.21K | 30.14%-6.74K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 8.68%-2.95K | -486.11%-9.24K | -77.13%-6.18K | -27.57%-29.61K | -216.28%-21.31K | 13.95%-3.23K | 81.09%-1.58K | 20.36%-3.49K | 8.75%-23.21K | 30.14%-6.74K |
| Diluted earnings per share | 0 | 0 | 0 | -0.01 | -0.01 | 0 | 0 | 0 | 0 | 0 |
| Basic earnings per share | 0 | 0 | 0 | -0.01 | -0.01 | 0 | 0 | 0 | 0 | 0 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.